# clm_AC2092994972

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: shares_outstanding  
value: 949,307,237 shares  
valid_from: 2023-10-30  
valid_to: 2024-02-16  
published: 2023-11-02  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_C1C0A1DB1A21  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company shares outstanding: 949,307,237 shares", as of 2023-10-30 (until 2024-02-16). Claim clm_AC2092994972, https://asof.is/claim/clm_AC2092994972, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947823000284/0000059478-23-000284-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2023, filed 2023-11-02  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947823000284/0000059478-23-000284-index.htm (primary, SEC EDGAR 10-Q Q3 FY2023, published 2023-11-02)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | shares_outstanding | 949,295,173 shares | valid 2023-08-03 to 2023-10-30 | conf 0.95 | superseded | superseded_by [clm_AC2092994972](/claim/clm_AC2092994972.md) | [clm_22F575B45357](/claim/clm_22F575B45357.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.